搜索临床试验以:PD-0332991
总计1173个结果
-
Innovent Biologics (Suzhou) Co. Ltd.主动,不招人
-
Hangzhou Hanx Biopharmaceuticals, Ltd.Wuhan Hanxiong Bioscience, Ltd.主动,不招人
-
St. Jude Children's Research HospitalPfizer; Gateway for Cancer Research完全的
-
SparX Biotech(Jiangsu) Co., Ltd.招聘中
-
Beijing 302 HospitalBeijing GD Initiative Cell Therapy Technology Co., Ltd.; Chinese Academy of Medical Sciences尚未招聘
-
Sichuan Cancer Hospital and Research Institute主动,不招人
-
The Affiliated Hospital of Qingdao University未知
-
ABL Bio, Inc.招聘中
-
First People's Hospital of HangzhouHangzhou Cancer Hospital招聘中
-
Innovent Biologics (Suzhou) Co. Ltd.终止
-
Shanghai Jiao Tong University Affiliated Sixth...招聘中
-
Shanghai Zhongshan Hospital主动,不招人
-
Zhejiang Cancer Hospital尚未招聘胃癌、HIPEC、抗 PD-1 抗体 Camrelizumab (SHR-1210)、化疗和手术中国
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Affiliated Cancer Hospital of Shantou University... 和其他合作者招聘中
-
Tianjin Medical University Cancer Institute and...招聘中
-
Beijing 302 HospitalBeijing GD Initiative Cell Therapy Technology Co., Ltd.; Chinese Academy of Medical Sciences尚未招聘
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Agenus Inc.; Dutch Cancer Society尚未招聘
-
BioAtla, Inc.招聘中
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
BioAtla, Inc.招聘中黑色素瘤 | 头颈癌 | 非小细胞肺癌 | 三阴性乳腺癌美国, 香港, 台湾, 西班牙, 希腊, 德国, 意大利, 波兰
-
Shandong New Time Pharmaceutical Co., LTD未知
-
Dragonboat Biopharmaceutical Company LimitedFudan University招聘中